This website uses tracking technologies, such as cookies, to provide a better user experience. If you continue to use this site, then you acknowledge our use of tracking technologies. For additional information, review our Privacy Policy.
Cancer Research Institute has published a comprehensive analysis of the current clinical trial landscape of anti PD-1/L1 immune checkpoint inhibitors.
The Cancer Research Institute has published an updated global immuno-oncology landscape analysis highlighting a robust pipeline marked by rapid growth.
The study explores a potential non-invasive approach to identify tumor mutations.
Drs. Miriam Merad and Padmanee Sharma will be honored with the 2018 William B. Coley Award, while Dr. Boris Reizis will receive the Frederick W. Alt Award
The Cancer Research Institute announced that it will honor biotechnology company Regeneron, and journalist and filmmaker Perri Peltz with the 2018 Oliver R. Grace Award for Distinguished Service in Advancing Cancer Research.
Contact Us
Cancer Research Institute | National Headquarters 29 Broadway, Floor 4 | New York, NY 10006-3111
800-992-2623212-832-9376Staff Directory
This September for Childhood Cancer Awareness Month, we look at how we’re working toward a future immune to childhood cancer.
This September for Blood Cancer Awareness Month, we look at how we’re working toward a future immune to leukemia, lymphoma, and multiple myeloma.